Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

BARDA awards contract to RxBio to develop radiomitigant countermeasure drug

Nov. 9, 2011

Novel radioprotective agents divulged by Peter MacCallum Cancer Centre

Nov. 7, 2011

NIH grant awarded for AEOL-10150 as medical countermeasure against nerve agents

Oct. 27, 2011

FDA provides update on safety review of Chantix

Oct. 26, 2011

FDA grants accelerated approval to ApoPharma's Ferriprox

Oct. 18, 2011

G-Zero Therapeutics receives NIH grant for studies in radiation exposure

Oct. 5, 2011

Nanotherapeutics receives U.S. government contract to develop oral radiation drug

Oct. 4, 2011

OX-219 shows promise in patients with opioid dependence

Sep. 22, 2011

Rare Disease Therapeutics selects distributor for Anascorp

Sep. 15, 2011

Pluristem's PLX cells show promise in preclinical studies

Sep. 9, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...